Meetings. Abstracts: AACR Special Conference on Modernizing Population Sciences in e Digital Age February 19–22, . San Diego, CA. Proceedings: AACR Annual Meeting ch 29–April 3, . Atlanta, GA. AACR Abstract Submission Guidelines Au ors who submit an abstract of a paper confirm at ey have not previously published ese data, at ey have not previously presented em at a large national annual scientific meeting, and at ey are not planning to present or publish em prior to e dates of is AACR conference. Accepted abstracts will also be published as an online-only Proceedings supplement to an AACR journal after e completion of e meeting. NOTIFICATION OF ABSTRACT STATUS All individuals listed as ABSTRACT PRESENTERS will be notified of acceptance or rejection by email approximately two (2) weeks after e abstract submission deadline. Proceedings: AACR Annual Meeting . ch 29-April 3, . Atlanta, GA Background High TMB is predictive of PFS benefit wi anti-PD-(L)1 ± anti-CTLA-4 erapy in mNSCLC. Preliminary results from MYSTIC ([NCT02453282]), an open-label, Phase III trial of first-line durvalumab (D. anti-PD-L1), ± tremelimumab (T. anti-CTLA-4), vs platinum-based chemo erapy (CT) in mNSCLC, indicate at. 22, · Li TW, Jones PA. Me ylation changes in early embryonic genes in cancer [abstract]. In: Proceedings of e 97 Annual Meeting of e American Association for Cancer Research. 2006 Apr 1–5. Washington, DC. Philadelphia (PA): AACR. 2006. Abstract nr 30. ABSTRACT SUBMISSION SCOPE OF WORK. Abstract submission will open in mid-ober and will close on uary 15, 2021. All abstracts must be submitted online. Abstract submission notifications will be sent via email by e end of ch. One abstract submission system allows you to present your research at ree outstanding meetings! e AUA Annual. As of e 1, e only meeting requiring a submission fee is e AACR Annual Meeting. No o er meeting or conference requires an abstract submission fee. Do I have to be an AACR member to submit an abstract? Nonmembers submit abstracts to any AACR meeting or conference. Proceedings: AACR Annual Meeting . ch 29-April 3, . Atlanta, GA Background: Checkpoint inhibitors such as anti-PD-1 are ineffective as single agents for patients (pts) wi PDAC. Preclinical data suggest at chemo erapy wi agonistic CD40 antibodies can be combined wi anti-PD-1 to trigger effective T cell immunity. We conducted a multi-center, open label clinical trial. Abstracts and posters are organized by category, in alphabetical order by cancer center. ♦ Featured Poster * Poster Present at Meeting Categories: Clinical Research Operations Finance/CCSG/PRMS Investigator-Initiated Trials Regulatory Training and Quality Assurance Trial Recruitment and Disparities Research Trial Start-up/Closure. e AACR Annual Meeting program covers e latest discoveries across e spectrum of cancer research—from population science and prevention. to cancer biology, translational, and clinical studies. to survivorship and advocacy—and highlights e work of e best minds in research and medicine from institutions all over e world. 25, · Hosted by e European Organisation for Research and Treatment of Cancer (EORTC), e National Cancer Institute (NCI) and e American Association for Cancer Research (AACR), e Symposium attracts academics, scientists and pharmaceutical industry representatives from across e globe to discuss e latest in ations in drug development, target selection and e impact of . 01, · AACR accepting abstracts for meeting. ober 1, . e American Association for Cancer Research (AACR) will highlight e latest work of e best minds in cancer research and medicine from institutions all over e world at e AACR annual meeting in San Diego. e meeting, titled Turning Science into Lifesaving Care. Proceedings: AACR Annual Meeting . ch 29-April 3, . Atlanta, GA Introduction: High Tumor Mutational Burden (TMB) has shown association wi benefit from immune checkpoint blockade erapies. While TMB as computed from whole exome sequencing (WES) is still a gold standard, e high input material (tumor and germline DNA) requirement and complex bioinformatics refrains exploring . e AACR is a 501c3 nonprofit whose mission is to prevent and cure cancer rough research, education, communication, collaboration, funding, and advocacy. Proceedings: AACR Annual Meeting . ch 29-April 3, . Atlanta, GA Background Tumor Treating Fields (TTFields) are an anti-mitotic, regional treatment modality, utilizing low intensity alternating electric fields delivered non-invasively to e tumor using a portable device. In-vitro, human meso elioma cells were highly susceptible to TTFields. TTFields plus chemo erapy have. Proceedings: AACR Annual Meeting . ch 29-April 3, . Atlanta, GA Background: Tumor Treating Fields (TTFields) are non-invasive, loco-regional, anti-mitotic treatment modality comprising low intensity alternating electric fields. TTFields has demonstrated efficacy in non-small cell lung cancer (NSCLC) in in vitro and in vivo models, and in a Phase I/II clinical study. Proceedings: AACR Annual Meeting . ch 29-April 3, . Atlanta, GA e microenvironment generated by tumor cells and suppressive stromal cells creates unfavorable conditions for effector immune cells in order to escape anti-tumor immunity. Besides suppressive pa ways like for example e CD39/CD73 axis, mechanisms including nutrient starvation, hypoxia, exposure to high levels of. More information about e AACR Annual Meeting will be available online and in e Call for Abstracts in late ust . Key Dates t. 24, : Abstract Submission Opens. All accepted abstracts will be presented as posters during e meeting. From all accepted entries, e abstract committee will select abstracts to be presented as short-talks. Please indicate during abstract submission whe er you would prefer to only present a poster or, if selected, to give a short talk as well. Proceedings: AACR Annual Meeting . ch 29-April 3, . Atlanta, GA Background: e phase 2 TRITON2 ([NCT02952534]) study is evaluating e poly(ADP-ribose) polymerase inhibitor rucaparib in mCRPC patients wi a deleterious germline or somatic mutation in BRCA1, BRCA2, ATM, or 1 of 12 o er DNA damage repair (DDR) genes who have progressed on prior androgen receptor-directed. e Call for Abstracts for Virtual COSM 2021 is now open! COSM 2021 will offer a range of educational opportunities including oral presentations, panels, fireside chats, keynote lectures, product demos, and posters. Attendees will have access to all nine Societies’ content and earn CME virtually! COSM is e premier educational and technology forum for providing e sub Read more». Annual Meeting of e American Association for Cancer Research is organized annually. e annual meeting continues to grow! It will be expected to reach 26000 attendees is year. Key Dates. Abstract Submission Opens: Wednesday, 30, . NextGen Stars Application Submission Deadline: ursday, ober 1, . Disclaimer. e abstract or collection of abstracts do not constitute an endorsement by e Or opaedic Research Society (ORS) of e product, assay or information contained herein.. No responsibility is assumed, and responsibility is hereby disclaimed, by e ORS for any injury and/or damage to persons or property as a matter of product liability, negligence or o erwise, or from any use. 04, · Abstracts at have been selected for inclusion in e AACR press program will be made publicly available at e date and time of presentation, ei er at e meeting or an official AACR press conference. After e meeting, your abstract will be published in an online-only supplement to e AACR journal Cancer Research. AHNS International Conference on Head and Neck Cancer Survivorship rough Quality and In ation y 22-25, 2021 Hyatt Regency Chicago Chicago, Illinois If you have any questions, please contact e AHNS office: Email: [email protected] • Phone: 3 -437-0559 (ext. 118) • . 01, · Solid tumors be amenable to e drug strategy as well. In small cell lung cancer, for example, Halilovic's collaborators from Massachusetts General Hospital in Boston, MA, presented data at e AACR meeting showing at combined treatment wi BCL201 and a precursor to MIK665 induced regression in tumor models (Proceedings of e 1 Annual Meeting of e AACR, abstract . *CEST = Central European Summer Time. Publication schedule for accepted abstracts. Abstracts accepted for presentation at ESMO Congress as Poster (suffix P or TiP) will be published online via e ESMO website at 00:05 CEST on Monday, 23 .. Abstracts accepted for presentation at ESMO Congress as Proffered Paper (oral presentation) or Poster Discussion will be published. 19, · Clovis Oncology, Inc. (NASDAQ: CLVS) today announced at six abstracts highlighting progress in e Rubraca clinical development and lucitanib preclinical research programs will be presented at e American Association for Cancer Research (AACR) Annual Meeting taking place ch 29 – April 3 in Atlanta. e American Association for Cancer Research (AACR) annual meeting is being held virtually in April and e. View e NCI presentation and poster sessions available from part one of AACR. 28, · e AACR Annual Meeting will be held at e Georgia World Congress Center in Atlanta, Georgia from ch 29 to April 3. Posters will be available on Puma’s website following presentation. We are very pleased to announce at e San Antonio Breast Cancer Symposium will take place in . In response to e el coronavirus (COVID-19) global pandemic, e SABCS Executive Committee has made e ision, out of necessity to ensure e heal, safety and security of all SABCS attendees and e patients and communities ey serve, to hold e SABCS virtually. Late-breaking abstract submission site opens: Friday, y 24, Late-breaking abstract submission site closes: Sunday, ust 9, at 11:59 p.m. Pacific time Original research abstracts will be selected for late-breaking presentations based on scientific merit, timeliness and interest to ASTRO’s membership and attendees. e San Antonio Breast Cancer Symposium An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer. e San Antonio Breast Cancer Symposium is presented by e Cancer erapy & Research Center at UT Heal Science Center San Antonio, e American Association for Cancer Research, and Baylor College of Medicine. e Society for Epidemiologic Research (SER) will hold a Late-Breaker Session at e 48 Annual Meeting. is session will provide a forum for presentations of investigations, analyses, or me ods at have been conceived, conducted, and/or completed so recently at au ors could not meet e deadline for regular abstract submission (February 2, ). e abstract submission fee does not include registration for e annual meeting. erefore, all au ors planning to attend e ASH annual meeting must register for e meeting rough e ASH website. Electronic submission works optimally wi Microsoft Internet Explorer 7+, Mozilla Firefox 3.0+, and Safari or MAC OS .4+. e 34 Annual Meeting & Pre-Conference Programs of e Society for Immuno erapy of Cancer (SITC ) scheduled to take place . 6-, at e Gaylord National Hotel & Convention Center in National Harbor, Md.. Download e SITC Brochure. Important Dates. ch 26 – Member registration open April 9 – General attendee registration open. e eme of e AACR Annual Meeting , Driving In ative Cancer Science to Patient Care, is also e eme of is report. e report outlines all e ways in which AACR programs and initiatives support e efforts of investigators from e laboratory to e clinic to improve e lives of cancer patients. Midwest Meeting (Recorded Presentations) Midwest Meeting (Program) (Abstracts) (Recorded Presentations - Full Meeting) Midwest Meeting (Program) (Abstracts) (Recorded Presentations - Full Meeting). 20, · Oncolytic virus erapeutics-focused company Oncorus, Inc., announces an oral presentation on ONCR-177 at e upcoming AACR annual meeting. Contacts Media Contact: Liz Melone [email protected] Apr 01, · Presented at: American Association for Cancer Research (AACR) Annual Meeting . ch 29-April 3, . Atlanta, GA. Abstract LB-012/4. Sharpless, N. Opening ceremony. Presented at: American. Feb 28, · Data from Incyte’s Cancer Research Portfolio to be Featured in Seven Abstracts at e AACR Annual Meeting February 28, 08:00 AM Eastern Standard Time. Cookie Notice. is site uses tracking technologies rough e use of permanent cookies and web beacons/pixel tags. By default, cookies are set to Allow all cookies. . 19, · Clovis Oncology Announces Presentations at AACR Annual Meeting. Accepted abstracts highlight data from a phase 2 Examples of ford-looking statements contained in .